Q3 2025 Management View CEO David Solomon highlighted that Goldman Sachs delivered net revenues of $15.2 billion, earnings ...

Target's Q2 earnings report showed declining net sales, negative same-store sales growth, and lowered guidance. Learn why TGT ...

Sabra Health Care REIT is poised for FFO growth and SHOP-driven upside, offering a 6.6% yield with improving payout ratios.

The Bank of New York Mellon Corporation (BK) Q3 2025 Management View Robin Vince, President, CEO & Chairman of the Board, ...

Treasury called into the official conciliation process; bean counters told to make sense of labour cost reductions and where ...

As Diwali approaches, Mirae Asset Sharekhan identifies 12 promising stocks poised for growth in Samvat 2082. With strong ...

Out of the 47 analysts tracking HCLTech, 21 have a 'buy' rating on the stock, 19 recommend a 'hold', and seven suggest a 'sell', according to Bloomberg data. The average of 12-month analyst price ...

The bottom line is AI as a feature set has a crucial role to play in data governance and data protection – not only shielding ...

Tata Capital shares had a subdued debut on Monday, listing at Rs 330 on both BSE and NSE. Both Emkay Global Financial ...

Recursion Pharmaceuticals RXRX stock surged 16% in early October 2025 on renewed AI interest despite posting $171.9 million ...

Citing an extreme valuation, Wall Street analysts are expecting a pullback in the stock. The consensus price target of 28.29 ...

Compared with the closing price of HK$11.66 on 10 October, CLSA's target price implies an upside potential of 50%. Previously, several brokers including Soochow Securities and CMB International have ...